Cycrin combined with Estrace

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 1/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/20/2001 54 Female 503 lb 2/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/18/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/3/2002 56 Female 130 lb 12/23/2005 United States
Primary
Secondary
Transient Ischaemic Attack Other Serious 10/8/2003 63 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/10/1998 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 3/31/2003 63 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/8/2003 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/10/2001 54 Female 220 lb 2/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/16/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/14/1999 64 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/24/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 56 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 3/15/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/8/2003 66 Female 130 lb 2/27/2006 Consumer United States
Primary
Secondary
Metastases To Lymph Nodes Other Serious Female 2/28/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2004 Female 3/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/1997 56 Female 3/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/15/2001 49 Female 140 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/17/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 4/11/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 4/6/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1997 Female 4/19/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2002 Female 4/11/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/12/2006 United States
Primary
Secondary
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/1/1997 Female 4/19/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/24/2002 Female 5/1/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/24/2002 Female 4/25/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 5/3/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/18/2003 57 Female 122 lb 5/5/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2000 Female 5/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/24/2002 Female 4/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 5/11/2006 United States
Primary
Secondary
Metastases To Lymph Nodes Other Serious 7/18/2003 55 Female 5/12/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 9/15/1998 57 Female 5/24/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/17/1998 59 Female 5/24/2006 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/17/1998 59 Female 5/24/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/18/2003 55 Female 6/9/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/8/2003 66 Female 6/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 7/18/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 Female 7/20/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/18/2003 55 Female 7/19/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/5/1999 Female 7/25/2006 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/18/2003 57 Female 122 lb 7/20/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 7/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2000 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Oestrogen Receptor Assay Positive Other Serious 7/18/2003 57 Female 122 lb 7/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 69 Female 8/7/2006 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 11/1/2001 69 Female 8/3/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 74 Female 8/9/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 70 Female 192 lb 8/15/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 70 Female 8/9/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/1998 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/28/2001 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/24/2002 Female 9/5/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/24/2002 Female 9/1/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 8/8/2000 54 Female 122 lb 9/5/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/24/2002 Female 9/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2001 Female 12/29/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/1/2005 51 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 12/27/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/28/1999 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2001 Female 10/10/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 3/31/2004 65 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2001 53 Female 135 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/24/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 Female 10/10/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 5/4/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/17/1999 68 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/17/1998 52 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 9/15/1998 50 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/6/2000 66 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/24/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/22/2002 73 Female 140 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/11/1997 63 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 51 Female 140 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/7/2001 52 Female 188 lb 10/10/2006 United States
Primary
Secondary
Injury Other Serious 10/1/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 10/28/1999 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 1/29/2007 Lawyer
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 1/29/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/22/2003 Female 3/8/2007 Lawyer United States
Primary
Secondary
Ventricular Dysfunction Other Serious 2/1/1991 58 Female 3/15/2007 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious 4/22/2003 Female 3/16/2007 Lawyer United States
Primary
Secondary
Ultrasound Breast Abnormal Other Serious 1/1/2000 60 Female 180 lb 3/28/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/14/2003 58 Female 123 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/18/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/1999 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2001 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2003 61 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/4/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 55 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/12/2001 49 Female 140 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 60 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/1998 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/12/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2001 55 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2005 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Radiotherapy Other Serious 4/22/1994 57 Female 135 lb 5/10/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1997 56 Female 140 lb 6/5/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Required Intervention 4/24/2002 Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Required Intervention 1/1/2001 Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary

Drug Data